Bruce Hollis to Risk Factors
This is a "connection" page, showing publications Bruce Hollis has written about Risk Factors.
Connection Strength
0.742
-
Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol. 2015 Apr; 148:256-60.
Score: 0.058
-
Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May; 24(3):447-53.
Score: 0.052
-
Vitamin D efficacy and safety. Arch Intern Med. 2011 Feb 14; 171(3):266; author reply 267.
Score: 0.045
-
Vitamin D deficiency and insufficiency is common during pregnancy. Am J Perinatol. 2011 Jan; 28(1):7-12.
Score: 0.043
-
Does vitamin D make the world go 'round'? Breastfeed Med. 2008 Dec; 3(4):239-50.
Score: 0.038
-
Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2323-2331.
Score: 0.022
-
Modulating effect of vitamin D status on serum anti-adenovirus 36 antibody amount in children with obesity: National Food and Nutrition Surveillance. BMC Pediatr. 2020 06 27; 20(1):316.
Score: 0.021
-
Maternal Asthma, Preeclampsia, and Risk for Childhood Asthma at Age Six. Am J Respir Crit Care Med. 2019 09 01; 200(5):638-642.
Score: 0.020
-
Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1379-1387.
Score: 0.020
-
Impact of Preeclampsia on the Relationship between Maternal Asthma and Offspring Asthma. An Observation from the VDAART Clinical Trial. Am J Respir Crit Care Med. 2019 01 01; 199(1):32-42.
Score: 0.019
-
Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations =60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS One. 2018; 13(6):e0199265.
Score: 0.019
-
The Association of Maternal Asthma and Early Pregnancy Vitamin D with Risk of Preeclampsia: An Observation From Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):600-608.e2.
Score: 0.018
-
Maternal 25(OH)D concentrations =40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLoS One. 2017; 12(7):e0180483.
Score: 0.018
-
Vitamin D insufficiency in neonatal hypoxic-ischemic encephalopathy. Pediatr Res. 2017 07; 82(1):55-62.
Score: 0.017
-
Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest. 2016 12 01; 126(12):4702-4715.
Score: 0.017
-
Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months. Sci Rep. 2015 Jun 22; 5:10411.
Score: 0.015
-
Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1944-7.
Score: 0.014
-
Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014 Mar; 99(3):587-98.
Score: 0.014
-
Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013 Jun; 228(2):502-7.
Score: 0.013
-
Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control. 2013 Apr; 24(4):759-67.
Score: 0.013
-
Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci. 2012 Oct; 344(4):268-73.
Score: 0.013
-
Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med. 2012 Jun; 60(5):801-7.
Score: 0.012
-
Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer. 2012 Aug; 77(2):265-71.
Score: 0.012
-
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
Score: 0.012
-
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 02; 104(9):690-9.
Score: 0.012
-
Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One. 2011; 6(12):e28520.
Score: 0.012
-
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011 Oct; 5(6):538-68.
Score: 0.012
-
Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr. 2011 Aug; 106(3):339-44.
Score: 0.011
-
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res. 2011 May 11; 13(3):R50.
Score: 0.011
-
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011 Apr 20; 29(12):1599-606.
Score: 0.011
-
Blood vitamin d levels in relation to genetic estimation of African ancestry. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2325-31.
Score: 0.011
-
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009 Feb 15; 69(4):1439-47.
Score: 0.010
-
Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol. 2008 Nov; 117(11):864-70.
Score: 0.010
-
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008 Jul; 88(1):133-9.
Score: 0.009
-
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 09; 168(11):1174-80.
Score: 0.009
-
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 04; 100(11):796-804.
Score: 0.009
-
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 05; 98(7):451-9.
Score: 0.008
-
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1991-7.
Score: 0.008
-
Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006 Feb; 5(2):114-7.
Score: 0.008
-
Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005 Mar; 90(3):1557-62.
Score: 0.007
-
Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):533-7.
Score: 0.007
-
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):546-52.
Score: 0.007
-
The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum. 1999 Mar; 42(3):483-9.
Score: 0.005
-
Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology. 1998 Sep; 9(5):535-9.
Score: 0.005
-
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997 Jul; 8(4):615-25.
Score: 0.004
-
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1996 Feb; 5(2):121-6.
Score: 0.004
-
Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes Control. 1995 May; 6(3):235-9.
Score: 0.004
-
Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res. 1992 Jun; 7(6):647-57.
Score: 0.003